BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2452846)

  • 1. Induction of c-fos gene expression by interferons.
    Wan YJ; Levi BZ; Ozato K
    J Interferon Res; 1988 Feb; 8(1):105-12. PubMed ID: 2452846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells.
    Wan YJ; Orrison BM; Lieberman R; Lazarovici P; Ozato K
    J Cell Physiol; 1987 Feb; 130(2):276-83. PubMed ID: 3102507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive expression of c-fos antisense RNA blocks c-fos gene induction by interferon and by phorbol ester and reduces c-myc expression in F9 embryonal carcinoma cells.
    Levi BZ; Ozato K
    Genes Dev; 1988 May; 2(5):554-66. PubMed ID: 2454869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the 202 gene expression by interferons in L929 cells.
    Lembo D; Gaboli M; Caliendo A; Falciani F; Garattini E; Landolfo S
    Biochem Biophys Res Commun; 1992 Sep; 187(2):628-34. PubMed ID: 1382418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-fos antisense RNA blocks expression of c-fos gene in F9 embryonal carcinoma cells.
    Levi BZ; Kasik JW; Ozato K
    Cell Differ Dev; 1988 Nov; 25 Suppl():95-101. PubMed ID: 2463066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription.
    Collart MA; Belin D; Vassalli JD; Vassalli P
    J Immunol; 1987 Aug; 139(3):949-55. PubMed ID: 3110291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of fibroblasts with activated c-myc confers resistance to antigrowth effects of interferon.
    Einat M; Kimchi A
    Oncogene; 1988 May; 2(5):485-91. PubMed ID: 2453829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of C1-inhibitor synthesis by interferons and other agents.
    Lappin D; Whaley K
    Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: alpha, beta, and gamma.
    Morikawa K; Morikawa R; Killion JJ; Fan D; Fidler IJ
    J Natl Cancer Inst; 1990 Mar; 82(6):517-22. PubMed ID: 2138228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
    Hall SH; Berthelon MC; Avallet O; Saez JM
    Endocrinology; 1991 Sep; 129(3):1243-9. PubMed ID: 1651842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by interferons of the expression of monocyte complement genes.
    Lappin DF; Birnie GD; Whaley K
    Biochem J; 1990 Jun; 268(2):387-92. PubMed ID: 1694661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
    Sariban E; Mitchell T; Griffin J; Kufe DW
    J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene induction by type I and type II interferons and their combination.
    Sanda C; Weitzel P; Tsukahara T; Schaley J; Edenberg HJ; Stephens MA; McClintick JN; Blatt LM; Li L; Brodsky L; Taylor MW
    J Interferon Cytokine Res; 2006 Jul; 26(7):462-72. PubMed ID: 16800785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells.
    Okazaki R; Ikeda K; Sakamoto A; Nakano T; Morimoto K; Kikuchi T; Urakawa K; Ogata E; Matsumoto T
    J Bone Miner Res; 1992 Oct; 7(10):1149-55. PubMed ID: 1456083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
    Kushtai G; Barzilay J; Feldman M; Eisenbach L
    Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor, but not thyrotropin, stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture.
    Heldin NE; Westermark B
    Endocrinology; 1988 Mar; 122(3):1042-6. PubMed ID: 3125035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.